Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$677B
| $1.52B | 0.41% |
17,110,141
+158,584
| +0.9% | +$13.6M |
|
27
Johnson & Johnson
JNJ
$635B
| $1.51B | 0.41% |
12,129,259
+1,776,657
| +17% | +$212M |
|
28
Alphabet (Google) Class C
GOOG
$3.9T
| $1.48B | 0.4% |
35,746,560
+3,844,160
| +12% | +$158M |
|
29
Pfizer
PFE
$140B
| $1.41B | 0.38% |
43,495,310
+3,633,978
| +9% | +$115M |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $1.41B | 0.38% |
5,892,879
+1,295,834
| +28% | +$302M |
|
31
GE Aerospace
GE
$367B
| $1.36B | 0.37% |
9,496,462
+1,516,256
| +19% | +$219M |
|
|
RAI
32
DELISTED
Reynolds American Inc
RAI
| $1.27B | 0.34% |
20,092,008
+7,419,558
| +59% | +$446M |
|
33
Procter & Gamble
PG
$343B
| $1.2B | 0.33% |
13,396,747
+1,237,382
| +10% | +$110M |
|
|
34
iShares MSCI Emerging Markets ETF
EEM
$28B
| $1.19B | 0.32% |
30,304,674
+18,723,750
| +162% | +$711M |
|
|
35
Invesco QQQ Trust
QQQ
$455B
| $1.19B | 0.32% |
8,978,606
-4,720,209
| -34% | -$603M |
|
36
Oracle
ORCL
$331B
| $1.13B | 0.31% |
25,333,439
-2,773,153
| -10% | -$115M |
|
37
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.44B
| $1.11B | 0.3% |
40,291,074
+1,516,258
| +4% | +$40.8M |
|
38
PUT
Apple
AAPL
$4.89T
| $1.1B | 0.3% |
30,734,000
-19,010,080
| -38% | -$626M |
|
39
General Motors
GM
$74.7B
| $1.07B | 0.29% |
30,151,951
-2,121,600
| -7% | -$77.6M |
|
40
Cisco
CSCO
$450B
| $1.06B | 0.29% |
31,409,195
+441,594
| +1% | +$14.3M |
|
41
Abbott
ABT
$180B
| $1.06B | 0.29% |
23,833,670
-439,023
| -2% | -$19M |
|
42
AT&T
T
$165B
| $1.06B | 0.29% |
33,653,225
+3,559,428
| +12% | +$112M |
|
43
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $1.05B | 0.28% |
11,932,400
+9,593,500
| +410% | +$838M |
|
44
Enterprise Products Partners
EPD
$83.8B
| $1.03B | 0.28% |
37,182,079
+3,046,896
| +9% | +$85.1M |
|
|
45
Intuitive Surgical
ISRG
$121B
| $1.03B | 0.28% |
12,053,790
+9,538,236
| +379% | +$753M |
|
46
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.01B | 0.27% |
6,053,801
+826,165
| +16% | +$138M |
|
47
Comcast
CMCSA
$79.1B
| $977M | 0.27% |
26,001,560
-2,113,592
| -8% | -$78.4M |
|
48
iShares Russell 1000 Value ETF
IWD
$82B
| $971M | 0.26% |
8,451,872
+346,283
| +4% | +$39.7M |
|
49
American Tower
AMT
$77.7B
| $971M | 0.26% |
7,992,835
+839,910
| +12% | +$92.4M |
|
50
Merck
MRK
$324B
| $968M | 0.26% |
15,972,517
+3,072,697
| +24% | +$186M |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.